Ferring Pharmaceuticals creates Executive Board

Ferring Pharmaceuticals creates Executive Board
February 19, 2009 pulse

Ferring Pharmaceuticals creates Executive Board

Saint-Prex, Switzerland – 19 February, 2009 –

Today, Ferring Pharmaceuticals announced the creation of a new Executive Board. This reflects the substantial growth of the company over the past few years and the subsequent need to adapt the management structure. The Executive Board will be led by Michel Pettigrew, President of the Executive Board and Chief Operating Officer, and will report to the Board of Directors.

Frederik Paulsen, Chairman of Ferring Pharmaceuticals, said;
“This is a very important step in the development of Ferring. We have enjoyed considerable success over the past few years, and grown substantially. This will help us consolidate our position and push on to the next phase of our growth.”

The Executive Board will have collective responsibility for all aspects of the company’s operational management, including legal and ethical compliance and Ferring’s Standard Operating procedures. It will also, importantly, manage adherence to the Ferring Philosophy, the values which underpin the company’s activities.

Michel Pettigrew, commenting on his appointment, said:
“I am delighted to have been appointed President of the Executive Board. Ferring has expanded considerably into new geographies and markets and the Executive Board will strengthen our corporate professionalism and efficiency, and help position us for further success globally in the future.”

As well as Michel Pettigrew, the Executive Board will comprise, Peter Wilden (Chief Financial Officer), Pascal Danglas (Executive Vice-President Clinical & product development), and Jean Duvall (Group General Counsel).

– ENDS –

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a Swiss-based research driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology, fertility and urology. In recent years Ferring has expanded beyond its traditional European base and has operations in over 40 countries. To learn more about Ferring or its products please visit www.ferring.com.

For more information, please contact

Helen Gallagher
Ferring Pharmaceuticals
+41 58 301 00 51
+41 58 301 0039
helen.gallagher@ferring.com

Press Kit
Press release in English View
Communiqué de presse en français View

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK